Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125982101 | 12598210 | 1 | I | 20160715 | 20160726 | 20160726 | EXP | GB-TEVA-678267ACC | TEVA | 61.00 | YR | M | Y | 0.00000 | 20160727 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125982101 | 12598210 | 1 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | U | U | 0 | ||||||||||
125982101 | 12598210 | 2 | PS | MIRTAZAPINE. | MIRTAZAPINE | 1 | U | U | 76119 | ||||||||||
125982101 | 12598210 | 3 | SS | SIMPONI | GOLIMUMAB | 1 | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125982101 | 12598210 | 1 | Product used for unknown indication |
125982101 | 12598210 | 2 | Product used for unknown indication |
125982101 | 12598210 | 3 | Psoriatic arthropathy |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125982101 | 12598210 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125982101 | 12598210 | Arrhythmia | |
125982101 | 12598210 | Depression | |
125982101 | 12598210 | Erectile dysfunction | |
125982101 | 12598210 | Headache |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |